METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental T-Cell therapy for liver cancer halted early
Disease control TerminatedThis study tested a new treatment called ET140203 T cells for people with advanced liver cancer that had not responded to other therapies. The treatment involved taking a patient's own immune cells, modifying them to target cancer, and giving them back. The study was stopped earl…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 07:14 UTC
-
Liver cancer software tool tested, but study ends early
Knowledge-focused TerminatedThis pilot study tested a software called BioTraceIO 360, designed to help doctors plan and monitor liver tumor ablation (a procedure that destroys tumors with heat). The study aimed to enroll 30 people with liver cancer, but was terminated early with only 4 participants. The goa…
Matched conditions: METASTATIC LIVER CANCER
Phase: NA • Sponsor: Techsomed Medical Technologies LTD • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC